L-arginine metabolism in early-onset and late-onset pre-eclamptic pregnancies

References

• Duley L. The global impact of pre-eclampsia and eclampsia. Semin Perinatol 2009;3:130–7.
   Google Scholar
• Myatt L, Webster RP. Vascular biology of pre-eclampsia. J Thromb Haemost 2009;7:375–84.
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Placental stress and pre-eclampsia: a revised view. Placenta 2009;30:473–82.
   PubMed Web of Science ®Google Scholar
• Kobayashi T, Tokunaga N, Isoda H, Kanayama N, Terao T. Vasospasms are characteristic in cases with eclampsia/ pre-eclampsia and HELLP syndrome: proposal of an angiospastic syndrome of pregnancy. Semin Thromb Hemost 2001;27:131–5.
   PubMed Web of Science ®Google Scholar
• Huppertz B. Placental origins of pre-eclampsia: challenging the current hypothesis. Hypertension 2008;51:970–5.
   PubMed Web of Science ®Google Scholar
• Roberts JM. Objective evidence of endothelial dysfunction in pre-eclampsia. Am J Kidney Dis 1999;33:992–4.
   PubMed Web of Science ®Google Scholar
• Moffett A, Hiby SE. How does the maternal immune system contribute to the development of pre-eclampsia. Placenta 2007;28(Suppl. A):S51–6.
   Google Scholar
• Hubel CA. Oxidative stress in the pathogenesis of pre- eclampsia. Proc Soc Exp Biol Med 1999;222:222–5.
   PubMed Web of Science ®Google Scholar
• Sladek SM, Magness RR, Conrad KP. Nitric oxide and pregnancy. Am J Physiol 1997;272:R441–3.
   PubMed Web of Science ®Google Scholar
• Khalil RA, Granger JP. Vascular mechanisms of increased arterial pressure in pre-eclampsia: lessons from animal models. Am J Physiol Regul Integr Comp Physiol 2002; 283:R29–45.
   PubMed Web of Science ®Google Scholar
• Böger RH, Diemert A, Schwedhelm E, Lüneburg N, Maas R, Hecker K. The role of nitric oxide synthase inhibition by asymmetric dimethylarginine in the pathophysiology of pre-eclampsia. Gynecol Obstet Invest 2010; 69:1–13.
   PubMed Web of Science ®Google Scholar
• Forstermann U, Closs E, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H.Nitric oxide synthase isoenzymes: characterization, purification, molecular cloning, and functions. Hypertension 1994;23:1121–31.
   PubMed Web of Science ®Google Scholar
• Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure. Lancet 1992;339:572–5.
   PubMed Web of Science ®Google Scholar
• Böger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Böger SM. LDL cholesterol upregulates synthesis of asymmetric dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine-dependent methyltransferases. Circ Res 2000;87; 99–105.
   PubMed Web of Science ®Google Scholar
• Cooke JP. Does ADMA cause endothelial dysfunction?Arterioscler Thromb Vasc Biol 2000;20:2032–2037.
   PubMed Web of Science ®Google Scholar
• Böger RH. The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor. Cardiovasc Res 2003;59:824–33.
   PubMed Web of Science ®Google Scholar
• Calver A, Collier J, Leone A, Moncada S, Vallance P. Effect of local intra-arterial asymmetric dimethylarginine (ADMA) on the forearm arteriolar bed of healthy volunteers.J Human Hypertens 1993;7:193–4.
   PubMed Web of Science ®Google Scholar
• Böger R. Lentz SR, Bode-Böger SM, Knapp HR, Haynes WG. Elevation of asymmetric dimethylarginine may mediate endothelial dysfunction during experimental hyperhomocyst (e)inaemia in humans. Clin Sci 2001;100:161–7.
   PubMed Web of Science ®Google Scholar
• Closs EI, Bascha Fz, Habermeier A, Forstermann U. Interferences of l-arginine analogues with l-arginine transport mediated by the y+ carrier hCAT-2B. Nitric Oxide 1997; 1:65–73.
   PubMed Web of Science ®Google Scholar
• MacAllister RJ, Parry H, Kimoto M, Ogawa T, Russel RJ, Hodson H, Whitley GS, Vallance P. Regulation of nitric oxide synthesis by dimethylarginine dimethylaminohydrolase. BrJ Pharmacol 1996;119:1533–40.
   PubMed Web of Science ®Google Scholar
• Pettersson A, Hedner T, Milsom I. Increased circulatory concentrations of asymmetric dimethyl arginine (ADMA), an endogenous inhibitor of nitric oxide synthesis, in pre-eclampsia. Acta Obstet Gynecol Scand 1998,77:808–13.
   PubMed Web of Science ®Google Scholar
• Kim YJ, Park HS, Lee HY, Ha EH, Suh SH, Oh SK, Yoo HS. Reduced l-arginine level and reduced placental eNOS activity in pre-eclampsia. Placenta 2006;27: 438–44.
   PubMed Web of Science ®Google Scholar
• Lowe DT. Nitric oxide dysfunction in the pathophysiology of pre-eclampsia. Nitric Oxide 2000;4:441–58.
   PubMed Web of Science ®Google Scholar
• Fickling SA, Williams D, Vallance P, Nussey SS, Whitley GS. Plasma concentrations of endogenous inhibitor of nitric oxide synthesis in normal pregnancy and pre-eclampsia. Lancet 1993;342:242–3.
   PubMed Web of Science ®Google Scholar
• Holden DP, Fickling SA, Whitley GS, Nussey SS. Plasma concentration of asymmetric dimethylarginine, a natural inhibitor of nitric oxide synthase, in normal pregnancy and pre-eclampsia. Am J Obstet Gynecol 1998;178:551–6.
   PubMed Web of Science ®Google Scholar
• Speer PD, Powers AW, Frank MP, Harger G, Markovic N, Roberts JM. Elevated asymmetric dimethylarginine concentrations precede clinical pre-eclampsia, but not pregnancies with small-for-gestational age infant. Am J Obstet Gynecol 2008;198:112e1–7.
   PubMed Web of Science ®Google Scholar
• Wang Y, Gu Y, Zhang Y, Lewis D. Evidence of endothelial dysfunction in pre-eclampsia: decreased endothelial nitric oxide synthase expression is associated with increased cell permeability in endothelial cells from pre-eclampsia. Am J Obstet Gynecol 2004;190:817–24.
   PubMed Web of Science ®Google Scholar
• Schiessl B, Mylonas I, Hantschmann P, Kuhn C, Schulze S, Kunze S, Friese K, Jeschke U. Expression of endothelial NO synthase, inducible NO synthase, and estrogen receptors alpha and beta in placental tissue of normal, pre-eclamptic, and intrauterine growth-restricted pregnancies. J Histochem Cytochem 2005;53:1441–9.
   PubMed Web of Science ®Google Scholar
• Akbar F, Heinonen S, Pirskanen M, Uimari P, Tuomainen TP, Salonen JT. Haplotypic association of DDAH1 with susceptibility to pre-eclampsia. Mol Hum Reprod 2004;11:73–7.
   PubMed Web of Science ®Google Scholar
• Wang Z, Tang WWH, Cho L, Brennan DM, Hazen SL. Targeted metabolomic evaluation of arginine methylation and cardiovascular risks. Potential mechanisms beyond nitric oxide synthase inhibition.Arterioscler Thromb Vasc Biol 2009;29:1383–91.
   PubMed Web of Science ®Google Scholar
• Noris M, Todeschini M, Cassis P, Pasta F, Cappellini A, Bonazzola S, Macconi D, Maucci R, Porrati F, Benigni A, Picciolo L, Remuzzi G. L-arginine depletion in pre-eclampsia orients nitric oxide synthase toward oxidant species. Hypertension 2004;43:614–22.
   PubMed Web of Science ®Google Scholar
• Raymond D, Peterson E. A critical review of early-onset and late-onset pre-eclampsia. Obstet Gynecol Surv 2011; 66:497–506.
   PubMed Web of Science ®Google Scholar
• Martens-Lobenhoffer J, Bode-Böger SM. Fast and efficient determination of arginine, symmetric dimethylarginine and asymmetric dimethylarginine in biological fluids by hydrophillic-interaction liquid chromatography-electrospray tandem mass spechometry. Clin Chem 2006;42:488–93.
   Google Scholar
• Martens-Lobenhoffer J, Postel S, Troger U, Bode-Böger SM. Determination of ornithine in human plasma by hydrophilic interaction chromatography-electrospray tandem mass spectroscopy. J Chromatogr 2007;855:271–5.
   Web of Science ®Google Scholar
• Jenkinson CP, Grody WW, Cederbaum SP. Comparative properties of arginases. Comp Biochem Physiol 1996;114B: 107–32.
   Google Scholar
• Bachetti T, Comini L, Francolini G, Bastianon D, Valetti B, Cadei M, Grigolato P, Suzuki H, Finazzi D, Albertini A, Curello S, Ferrari R. Arginase pathway in human endothelial cells in pathophysiological conditions. J Mol Cell Cardiol 2004;37:515–23.
   PubMed Web of Science ®Google Scholar
• Li H, Meininger CJ, Hawker JR, Haynes TE, Kepka- Lenhart D, Mistry SK. Morris SM Jr, Wu G. Regulatory role of arginase I and II in nitric oxide, polyamine, and proline synthesis in endothelial cells. Am J Physiol Endocrinol Metab 2001;280:E75–82.
   PubMed Web of Science ®Google Scholar
• Berka V, Wu G, Yeh HC, Palmer G, Tsai AL. Three different oxygen-induced radical species in endothelial nitric oxide synthase oxygenase domain under regulation by arginine and tetrahydrobiopterin. J Biol Chem 2004;279:32243–51.
   PubMed Web of Science ®Google Scholar
• Durante W, Johnson FK, Johnson RA. Arginase: a critical regulator of nitric oxide synthesis and vascular function. Clin Exp Pharm Physiol 2007;34:906–11.
   PubMed Web of Science ®Google Scholar
• McDonald KK, Zharikov S, Block ER, Kilberg MS. A caveolar complex between the cationic amino acid transporter I and endothelial nitric-oxide synthase may explain the “arginine paradox”. J Biol Chem 1997;272:31213–6.
   PubMed Web of Science ®Google Scholar
• Buga GM, Singh R, Pervin S, Rogers NE, Schmitz DA, Jenkinson CP, Cederbaum SD, Ignarro LJ. Arginase activity in endothelial cells: Inhibition by Nω-hydroxy-l-arginine during high-output NO production. Am J Physiol 1996; 271:H1988–98.
   PubMedGoogle Scholar
• Hein TW, Zhang C, Wang W, Chang CI, Thengchaisri N, Kuo L. Ischemia-reperfusion selectively impairs nitric oxide-mediated dilatation in coronary arterioles: counteracting role of arginase. FASEB J 2003;17:2328–30.
   PubMed Web of Science ®Google Scholar
• Huynh NN, Chin-Dusting J. Amino acids, arginase and nitric oxide in vascular health. Clin Exp Pharm Physiol 2006;33:1–8.
   PubMed Web of Science ®Google Scholar
• Ueda S, Kato S, Matsuoka H, Kimoto M, Okuda S, Morimatsu M, Imaizumi T. Regulation of cytokin-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Circ Res 2003;92:226–33.
   PubMed Web of Science ®Google Scholar
• Sydow K, Münzel T. ADMA and oxidative stress. Atherosclerosis 2003;4(Suppl. 4):41–51.
   PubMed Web of Science ®Google Scholar
• Nelin L, Nash H, Chicoine L. Cytokin treatment increases arginine metabolism and uptake in bovine pulmonary artery arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 2001;281:L1232–9.
   PubMed Web of Science ®Google Scholar
• Sankaralingam S, Xu H, Davidge ST. Arginase contributes to endothelial cell oxidative stress in response to plasma from women with pre-eclampsia. Cardiovasc Res 2010; 85:194–203.
   PubMed Web of Science ®Google Scholar
• Facchinetti F, Longo M, Piccinini F, Neri I, Volpe A. L-arginine infusion reduces blood pressure in pre-eclamptic women through nitric oxide release. J Soc Gynecol Invest 1999;6:202–7.
   PubMedGoogle Scholar
• Staff AC, Berge L, Haugen G, Lorentzen B, Mikkelsen B, Henriksen T. Dietary supplementation with l-arginine or placebo in women with pre-eclampsia. Acta Obstet Gynecol Scand 2004;83:103–7.
   PubMed Web of Science ®Google Scholar
• Vadillo-Ortega F, Perichart- Perera O, Espino S, Avila- Vergara MA, Ibarra I, Ahued R, Godines M, Parry S, Macones G, Strauss JF. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high-risk population: randomised controlled trial. Brit Med J 2011;342:d2901.
   PubMed Web of Science ®Google Scholar
• Smeeth L, Williams D. Can a dietary supplement prevent pre-eclampsia? L-arginine with vitamins show promise, but there are good grounds for caution. BMJ 2011;342:d2777.
   Google Scholar